Financing ·
PMGC Holdings Inc. and its subsidiary NorthStrive Biosciences entered into a binding, interest-bearing payment…
ELABPMGC Holdings Inc.
PMGC Holdings Inc. and its subsidiary NorthStrive Biosciences entered into a binding, interest-bearing payment agreement with Longevity Health Holdings to secure royalty payments from the January 2025 sale of Elevai Skincare. The deal converts a 5% net sales royalty into scheduled monthly cash payments of $10,000 starting October 15, 2026, through August 28, 2031. Longevity acknowledged a 2025 royalty obligation of $94,937 accruing interest at the WSJ Prime Rate plus 1.00%. The agreement includes mandatory prepayments of 15% of net cash proceeds from capital raises exceeding $350,000 and annual audit rights. PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries.